ASX:BUL Blue Energy (BUL) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free BUL Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume54,950 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Blue Energy alerts: Email Address Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> About Blue Energy Stock (ASX:BUL)Blue Energy Limited, an energy company, explores, evaluates, and develops conventional and unconventional oil and gas resources primarily in Queensland and the Northern Territory in Australia. It holds 2P reserves of 71 PJ; 3P reserves of 298 PJ; and contingent resources of 3,011 PJ in ATP814P. The company was incorporated in 1992 and is based in Brisbane, Australia.Read More Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> BUL Stock News HeadlinesApril 23, 2024 | msn.comPrime energy, sports drinks contain PFAS and excessive caffeine, class action suits sayApril 23, 2024 | msn.comWhat Are Earth Signs? Everything to Know About Taurus, Virgo, and CapricornApril 26, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!April 22, 2024 | msn.comDisney+ Releases Surprise ‘Bluey’ EpisodeApril 22, 2024 | seekingalpha.comSCHD: If You've Won The Game, Take A Little Off The TopApril 20, 2024 | msn.com‘Bluey’: Disney+ Drops “Surprise” EpisodeApril 20, 2024 | msn.comTaurus zodiac sign: All about the personality traits, compatibility and love lifeApril 20, 2024 | msn.comWall Street faces make-or-break week with Tesla, GDP, inflation on deckApril 26, 2024 | Behind the Markets (Ad)The World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!April 11, 2024 | msn.comAnalyst overhauls S&P 500 target ahead of earnings seasonApril 11, 2024 | seekingalpha.comWorry About Inflation At Your Own Investment PerilApril 11, 2024 | msn.comYour Best Pet Match, According to AstrologyApril 5, 2024 | msn.com13 Dogs with Blue Eyes That Are StunningApril 3, 2024 | seekingalpha.comFLIN: Ride This Ultra Low-Cost ETF Into India's General ElectionsApril 3, 2024 | benzinga.comA Watershed Moment for GoldApril 3, 2024 | msn.comResearchers find a simple way to harvest more 'blue energy' from wavesApril 2, 2024 | msn.comA Perfectly Pragmatic, Teeny KitchenApril 2, 2024 | msn.comFamily Caregiver Program open to applicantsApril 1, 2024 | msn.comAnalysis-Relentless US credit demand seen driving second-quarter rallyApril 1, 2024 | finance.yahoo.comWe Ran A Stock Scan For Earnings Growth And Stellar Bancorp (NYSE:STEL) Passed With EaseMarch 30, 2024 | yahoo.comBrian Lunde driven to make a difference in JamestownMarch 30, 2024 | msn.comThe Week’s Investing News Roundup: Buffett Stocks, AI Stocks, MLPs, Cardano, and MoreMarch 29, 2024 | msn.com3 Market-Beating Stocks to Buy in AprilMarch 29, 2024 | msn.com5 Affordable Lowe's Lawn Mowers To Whip Your Lawn Into Shape This SpringMarch 29, 2024 | money.usnews.comHome Depot Bulks up Pro-Business With $18.25 Billion Deal for Building Products Supplier SRSMarch 29, 2024 | yahoo.com17 Pug Mixes That Make the Perfect PalsMarch 28, 2024 | money.usnews.comBoE's Haskel Says Rate Cuts 'Are a Long Way Off', FT ReportsSee More Headlines Receive BUL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Blue Energy and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/15/2018Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorOils/Energy Industry Oil & Gas E & P Sub-IndustryN/A Current SymbolASX:BUL CUSIPN/A CIKN/A Webwww.blueenergy.com.au Phone+61-7-32708800FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,175,810,048Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. John Charles Ellice-Flint AMP (Age 68)Exec. Chairman Mr. John M. PhillipsCEO, MD & Exec. DirectorMr. Stephen RodgersCompany Sec.Key Competitors1849520 (AWE.AX)ASX:AWEAker BP ASAOTCMKTS:DETNFAmazing Energy Oil and GasOTCMKTS:AMAZAnsila EnergyASX:ANAArgo ExplorationASX:AXTView All Competitors BUL Stock Analysis - Frequently Asked Questions How were Blue Energy's earnings last quarter? Blue Energy Limited (ASX:BUL) released its earnings results on Thursday, March, 15th. The company reported $0.00 earnings per share for the quarter. What other stocks do shareholders of Blue Energy own? Based on aggregate information from My MarketBeat watchlists, some companies that other Blue Energy investors own include EGF Theramed Health (EVAHF), DarioHealth (DRIO), (CKSNY) (CKSNY) and Agile Therapeutics (AGRX). This page (ASX:BUL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blue Energy Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
